Urigen Pharmaceuticals, Inc. (PRIVATE-NA:URGEN)

Urigen Pharmaceuticals, Inc. (PRIVATE-NA:URGEN)

Share Price
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Urigen Pharmaceuticals, Inc.

Urigen Pharmaceuticals is a global leader in non-oncological urology treatments. As the baby boomer population ages there is a growing patient population. We specialize in developing innovative products to ameliorate the cause and symptoms associated with urological ailments, specifically Interstitial Cystitis/Bladder Pain Syndrome ("BPS" or "IC/BPS"). Urology represents a specialty...

Sector: Pharmaceuticals [T3]
Website: www.urigen.com
col 3
col 4
col 5
col 6

Urigen Pharmaceuticals, Inc. Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use